Who Owns ClearPoint Neuro Stock?
NASDAQ: CLPTHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 52.48%
- Held by insiders
- 5.48%
- Institutional holders
- 182
- Institutions 52.5%
- Insiders 5.5%
- Public and other 42.0%
Who owns ClearPoint Neuro stock?
Institutional investors own about 52.5% of ClearPoint Neuro's shares, spread across 182 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 5.48% of CLPT.
The largest institutional holders are Blackrock Inc. (7.80%), MAK Capital One LLC (7.79%) and Vanguard Capital Management LLC (4.04%). Together, the top 10 institutions control 30.9% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their CLPT positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CLPT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 2.38M | 7.80% | +14.3% |
| MAK Capital One LLC | 2.38M | 7.79% | +24.9% |
| Vanguard Capital Management LLC | 1.23M | 4.04% | -0.9% |
| State Street Corporation | 816.55K | 2.68% | +20.1% |
| Geode Capital Management, LLC | 749.93K | 2.46% | +6.3% |
| Lane Generational LLC | 444.83K | 1.46% | -8.6% |
| UBS Group AG | 428.63K | 1.41% | -0.9% |
| Millennium Management Llc | 357.68K | 1.17% | +54.2% |
| Brown Advisory Inc. | 325.91K | 1.07% | 0.0% |
| Compass Financial Management LLC | 295.68K | 0.97% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CLPT
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 853.80K | 2.80% |
| iShares Trust-iShares Russell 2000 ETF | 725.82K | 2.38% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 351.98K | 1.15% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 308.61K | 1.01% |
| iShares Trust-iShares Russell 2000 Growth ETF | 266.76K | 0.87% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 148.47K | 0.49% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 142.24K | 0.47% |
| SPDR SERIES TRT-State Street SPDR S&P Kensho New Economies Composite E | 122.03K | 0.40% |
| SPDR SERIES TRUST-State Street SPDR S&P Health Care Equipment ETF | 96.85K | 0.32% |
| iShares Trust-iShares Micro-Cap ETF | 96.09K | 0.32% |
Frequently asked questions
Who is the largest shareholder of ClearPoint Neuro?
Blackrock Inc. is the largest institutional shareholder of CLPT, owning 7.80% of shares outstanding (2.38M shares) as of its latest 13F filing.
What percentage of ClearPoint Neuro is owned by institutions?
Institutions own about 52.5% of CLPT shares and 55.5% of the public float.
How much of ClearPoint Neuro do insiders own?
Insiders, such as officers and directors, own about 5.48% of CLPT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.